HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Hu, X. Articles by Limbird, L. E Search for Related Content PubMed PubMed Citation Articles by Hu, X. Articles by Limbird, L. E

Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
¹ Department of Biochemistry, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
² Department of Medicine (Diabetes, Endocrinology, and Metabolism), Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
⁴ Center for Computational Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA

(Requests for offprints should be addressed to L E Limbird, 464A Robinson Research Building, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600, USA; Email: lee.limbird{at}vanderbilt.edu)

The present studies extend recent findings that mice null for the _2A adrenergic receptor (_2A AR KO mice) lack suppression of exogenous secretagogue-stimulated insulin secretion in response to ₂ AR agonists by evaluating the endogenous secretagogue, glucose, ex vivo, and providing in vivo data that baseline insulin levels are elevated and baseline glucose levels are decreased in _2A AR KO mice. These latter findings reveal that the _2A AR subtype regulates glucose-stimulated insulin release in response to endogenous catecholamines in vivo. The changes in _2A AR responsiveness and resultant changes in insulin/glucose homeostasis encouraged us to utilize proteomics strategies to identify possible _2A AR downstream signaling molecules or other resultant changes due to perturbation of _2A AR expression. Although agonist stimulation of islets from wild type (WT) mice did not significantly alter islet protein profiles, several proteins were enriched in islets from _2A AR KO mice when compared with those from WT mice, including an enzyme participating in insulin protein processing. The present studies document the important role of the _2A AR subtype in tonic suppression of insulin release in response to endogenous catecholamines as well as exogenous ₂ agonists and provide insights into pleiotropic changes that result from loss of _2A AR expression and tonic suppression of insulin release.